MedTrace Logo

Stratus Versus Cirrus OCT in AMD

NCT00568191 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-12-05

No results posted yet for this study

Summary

The Cirrus OCT provides due to the spectral domain technology a 2-fold resolution than Stratus OCT generated in a comparable amount of time. Due to this higher resolution the retinal surface and the retinal pigment epithelium can be identified more clearly, a significantly reduced number of algorithm failures is expected

Conditions

  • Age-Related Macular Degeneration
  • Choroidal Neovascularization

Sponsors & Collaborators

  • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

    lead OTHER

Principal Investigators

  • Ilse Krebs · Ludwig Boltzmann Institute of Retinology and Biomicroscopic Lasersurgery

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Completion
2007-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00568191 on ClinicalTrials.gov